Skip to main content

Beta-Adrenoceptors in Heart Failure: A Mechanism or a cAMP Follower?

  • Conference paper

Abstract

In the myocardium of many patients with symptoms of heart failure there is a decrease in beta-adrenoceptor number, accompanied by a reduction in responsiveness to beta-agonists [3,5,8,10,16]. The hypothesis that this results simply from exposure to high circulating catecholamines is in dispute. The role of beta-adrenoceptor desensitisation in the progression of heart failure and the therapeutic implications are the subject of considerable debate.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anand IS, Ferrari R, Kalra GS. Wahi PL, Poole-Wilson PA, Harris P (1989) Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamics and plasma hormones in untreated congestive heart failure. Circulation 80: 299–305

    Article  PubMed  CAS  Google Scholar 

  2. Bayliss J, Norell M, Capena-Anson R, Sutton G, Poole-Wilson PA (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–22

    Article  PubMed  CAS  Google Scholar 

  3. Bohm M, Beuckelmann D. Brown L, Feiler G, Lorenz B, Nabauer M, Kemkes B, Erdmann E (1988) Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9: 844–852

    PubMed  CAS  Google Scholar 

  4. Bristow MR, Ginsburg R, Gilbert EM, Hershberger RE (1987) Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart. Basic Res Cardiol 82 (Suppl 2): 369–377

    PubMed  Google Scholar 

  5. Bristow MR, Ginsburg R, Minobe W. Cubicciotti RS, Sageman WS, Lurie K. Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 307: 205–211

    Article  PubMed  CAS  Google Scholar 

  6. Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W (1984) Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest 74: 212–223

    Article  PubMed  CAS  Google Scholar 

  7. Brodde OE (1988) The functional importance of beta 1 and beta 2 adrenoceptor in the human heart. A symposium: Focus on heart failure — current experiences in basic research and clinical studies on dopexamine hydrochloride (Dopacard), September 12–13. 1987. Paris, France. Proceedings. Am J Cardiol 62: 10–88C

    Article  Google Scholar 

  8. Brodde OE, Schuler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R. Reidmeister JC, Warnecke H. Zerkowski HR (1986) Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta,- and beta, -adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol 8: 1235–1242

    Article  PubMed  CAS  Google Scholar 

  9. Bronfman M, Morales MN, Orellana A (1988) Diacylglycerol activation of protein kinase C is modulated by long-chain ACYL-CoA. Biochem Biophys Res Commun 152: 987–992

    Article  PubMed  CAS  Google Scholar 

  10. Brown L, Lorenz B, Erdmann E (1986) Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res 20: 516–520

    Article  PubMed  CAS  Google Scholar 

  11. Chidsey CA, Braunwald EB, Morrow AG, Mason DT (1963) Myocardial norepinephrine concentration in man; effects of reserpine and of congestive heart failure. N Engl J Med 269: 653–658

    Article  PubMed  CAS  Google Scholar 

  12. Cohn JN, Levine TB. Olivari MT, Garberg V, Lura D, Francis GS. Simon AB. Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823

    Article  PubMed  CAS  Google Scholar 

  13. Erne P, Lipkin D, Maseri A (1988) Impaired beta-adrenergic receptor and normal postreceptor responsiveness in congestive heart failure. Am J Cardiol 61: 1132–1134

    Article  PubMed  CAS  Google Scholar 

  14. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase of the 40,000-mol wt pertussis toxin substrate ( G-protein) in the failing human heart. J Clin Invest 82: 189–197

    Article  PubMed  CAS  Google Scholar 

  15. Feldman MD, Copelas BS, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage failure. Circulation 2: 331–339

    Article  Google Scholar 

  16. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR (1986) Assessment of the Badrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290–1302

    Article  PubMed  CAS  Google Scholar 

  17. Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49: 1152–1156

    Article  PubMed  CAS  Google Scholar 

  18. Hirata Y (1988) Heterologous down-regulation of vascular atrial natriuretic peptide receptors by phorbol esters. Biochem Biophys Res Commun 152: 1097–1103

    Article  PubMed  CAS  Google Scholar 

  19. Hopwood AM, Harding SE, Harris P (1987) An antiadrenergic effect of adenosine on guinea-pig but not rabbit ventricles. Eur J Pharmacol 137: 67–75

    Article  PubMed  CAS  Google Scholar 

  20. Karliner JS, Alabaster C, Stephens H, Barnes P, Dollery C (1981) Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc Res 15: 296–304

    Article  PubMed  CAS  Google Scholar 

  21. Levitt M, Spector S. Sjoerdsma A, Undenfriend S (1965) Elucidation of the rate limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148: 1–8

    PubMed  CAS  Google Scholar 

  22. Mitsuhashi M, Payan DG (1988) Phorbol ester-mediated desensitization of histamine H! receptors on a cultured smooth muscle cell line. Life Sci 43: 1433–1440

    Article  PubMed  CAS  Google Scholar 

  23. Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P (1988) Increase in myocardial G;-proteins in heart failure. Lancet 2: 936–937

    Article  PubMed  CAS  Google Scholar 

  24. Pierpont G L, Francis GS, DeMaster EG, Olivari MT, Ring WT, Goldberg IF, Reynolds S, Cohn JN (1987) Heterologous myocardial catecholamine concentrations in patients with congestive heart failure. Am J Cardiol 60: 316–321

    Article  PubMed  CAS  Google Scholar 

  25. Reithmann C, Werdan K (1988) Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells. Eur J Pharmacol 154: 99–104

    Article  PubMed  CAS  Google Scholar 

  26. Scholz J, Schaefer B, Schmitz W, Scholz H, Steinfath M, Lohse M, Schwabe U, Puurunen J (1988) Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. J Pharmacol Exp Ther 245: 327–335

    PubMed  CAS  Google Scholar 

  27. Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ (1988) Phosphorylation of cell surface receptors: a mechanism for regulating signal transduction pathways. Endocr Rev 9: 38–56

    Article  PubMed  CAS  Google Scholar 

  28. Sole MJ, Helke CJ, Jacobwitz DM (1982) Increased dopamine in the failing hamster heart; transvesicular transport of dopamine limits the rate of norepinephrine synthesis. Am J Cardiol 49: 1682–1690

    Article  PubMed  CAS  Google Scholar 

  29. Tomlins B, Harding SE, Kirby MS, Poole-Wilson PA, Williams AJ (1986) Contamination of a cardiac sarcolemmal preparation with endothelial plasma membrane. Biochim Biophys Acta 856: 137–143

    Article  PubMed  CAS  Google Scholar 

  30. Turner JT, Bollinger DW, Toews ML (1988) Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist-and protein kinase C-mediated desensitization and further evidence for receptor internalization. J Pharmacol Exp Ther 247: 417–423

    PubMed  CAS  Google Scholar 

  31. Vescovo G, Kirby MS, Harding SE, Wanless RB, Anand IS, Poole-Wilson PA (1987) Responses to isoprenaline and calcium in myocytes isolated from the hearts of adriamycin-treated rabbits. J Mol Cell Cardiol 19 (Suppl 3): 312 (Abstract)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Harding, S.E., Poole-Wilson, P.A. (1991). Beta-Adrenoceptors in Heart Failure: A Mechanism or a cAMP Follower?. In: Lewis, B.S., Kimchi, A. (eds) Heart Failure Mechanisms and Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58231-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58231-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63509-0

  • Online ISBN: 978-3-642-58231-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics